Clinical Study

Characteristics and Patterns of Metastatic Disease from Chordoma

Table 6

Survival distribution among patients with metastasis stratified by location of metastatic disease.
(a) Case processing summary of patients included in analysis

Location of
primary metastasis
Total of eventsCensored
Percent

Bone3300%
Liver21150.0%
Lung1614212.5%
Soft tissue1100%

Overall2219313.6%

(b) Overall statistical comparison and test of equality of survival distributions

Chi-SquaredfSig.

Log rank (Mantel-Cox)11.26030.010

(c) Means and medians for survival time. Estimation is limited to the largest survival time if it is censored

Location of
primary metastasis
MeanMedian
95% Conf. interval95% Conf. interval
EstimateStd. errorLower boundUpper boundEstimateStd. errorLower boundUpper bound

Bone488.23264468.928.463.6
Liver81668.792.372N/AN/AN/A
Lung123.315.792.6154.11301.8126.4133.6
Soft tissue1330133133132N/AN/AN/A

Overall111.613.186137.412816.897.1163